INTRODUCTION: Complete resection with clear margins in locally advanced pelvic @entity5 , primary or recurrent, occasionally requires total pelvic exenteration (TPE). METHODS: We reviewed the results of EFA in 34 consecutive @entity1 operated on between June 2006 and December 2013. RESULTS: Median age was 62 (40-82) years; 24 (70%) were male. The @entity5 origin most frequent was advanced primary @entity5 (APRT), with 19 cases (55.9%) and most common type of exenteration was supraelevator (61.8%). R0 resection was achieved in 24 (70.6%) @entity1 and in 16 (85%) of the APRT. Fifteen (79%) @entity1 had pT4 APRT, and 4 (20%) pN +. Reconstruction of the bowel and bladder was performed with two stomas in 17 cases (50%), @entity14 and Bricker in 11 (32.3%) and wet double barreled colostomy in 6 (17.6%). There was no postoperative mortality; 23 (67,5%) @entity1 had complications, and 5 (14.6%) required a postoperative reoperation to solve them. Median follow-up was 23 (13-45) months. Overall survival (OS) and @entity66 ( @entity66 ) at 2 years were 67% and 58% respectively, and the median OS and @entity66 was 59 months (95% CI 26-110) and 39 months (95% CI 14-64), respectively. The @entity66 of R0 was significantly better (p=0.003) than R1. CONCLUSIONS: TPE is a potentially curative procedure for advanced pelvic @entity5 with similar morbi-mortality than other extended excisional surgery.

Total pelvic exenteration for the treatment of advanced primary or recurrent pelvic XXXX .

@entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'visceral tumors', 'rectal tumor', 'visceral malignancies'] @entity1 :: ('9606', 'Species') :: ['patients'] @entity66 :: ('MESH:D004194', 'Disease') :: ['disease free survival', 'DFS'] @entity14 :: ('MESH:D015179', 'Disease') :: ['colorectal anastomosis']
@entity5 :: (MESH:D009369,Disease) :: ['neoplasia']
